Personal information

Emails & domains

Verified email addresses

Websites & social links

Twitter
Research gate
LinkedIn

Countries

United Kingdom

Activities

Collapse all

Employment (5)

University College Hospital: London, London, GB

2021-04-26 to present | Research and development research radiographer (Radiotherapy and Proton Beam)
Employment
Source: Self-asserted source
Rita Simoes

Royal Marsden Hospital Chelsea: London, London, GB

2019-04-01 to present | Honorary research radiographer
Employment
Source: Self-asserted source
Rita Simoes

National Radiotherapy Trials Quality Assurance (RTTQA) Group: London, GB

2015-04-01 to present | Senior radiographer
Employment
Source: Self-asserted source
Rita Simoes

Mount Vernon Cancer Centre: Middlesex, Hertfordshire, GB

2013-01-28 to 2015-03-31 | Treatment Planning Radiographer (Radiotherapy Physics)
Employment
Source: Self-asserted source
Rita Simoes

Hospital de Santa Maria: Lisboa, Lisboa, PT

2008-06-17 to 2012-11-12 | Therapeutic Radiographer (Radiotherapy)
Employment
Source: Self-asserted source
Rita Simoes

Education and qualifications (3)

Institute of Cancer Research: London, London, GB

2019-04-01 to present | PhD student (Radiotherapy and Imaging)
Education
Source: Self-asserted source
Rita Simoes

Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa: Lisboa, Lisboa, PT

2010-02 to 2012-11 | MSc in Ionising Radiation applied to Health Sciences (Medical Physics)
Education
Source: Self-asserted source
Rita Simoes

Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa: Lisboa, Lisboa, PT

2004-09 to 2008-07 | BSc in Therapeutic Radiography (Radiotherapy)
Education
Source: Self-asserted source
Rita Simoes

Professional activities (5)

European SocieTy for Radiotherapy and Oncology: Brussels, BE

2022-04 to present | Radiation therapist (RTT) committee member
Invited position
Source: Self-asserted source
Rita Simoes

British Institute of Radiology: London, London, GB

2018-04 to present
Membership
Source: Self-asserted source
Rita Simoes

Society of Radiographers: London, London, GB

2017-01 to present
Membership
Source: Self-asserted source
Rita Simoes

European SocieTy for Radiotherapy and Oncology: Brussels, BE

2016-01 to present
Membership
Source: Self-asserted source
Rita Simoes

European SocieTy for Radiotherapy and Oncology: Brussels, BE

2015-12 to present | FALCON delineation workshops tutor and teacher
Invited position
Source: Self-asserted source
Rita Simoes

Funding (2)

Patient reported outcome measures developement for radiotherapy and proton beam therapy

2023-01 to 2024-01 | Grant
University College London Hospitals NHS Foundation Trust (London, GB)
Source: Self-asserted source
Rita Simoes

Minimising radiotherapy toxicities in soft tissue sarcoma of the extremities by developing radiotherapy planning dose-volume constraints for limb normal tissue structures

2019-04 to 2024-12 | Grant
National Institute for Health Research (Leeds, GB)
GRANT_NUMBER:

HEE / NIHR CDR-2018-04- ST2-004
Source: Self-asserted source
Rita Simoes

Works (35)

Do Patient-Reported Outcome Measures (PROMs) Used Within Radiotherapy Clinical Trials Reflect the Impact of Treatment?

Cancers
2024-11-14 | Journal article
DOI: 10.3390/cancers16223832
Contributors: Danielle Fairweather; Rachel M. Taylor; Laura Allington; Nazima Haji; Naomi Fersht; Yen-Ching Chang; Rita Simões
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose–volume constraints development: a study protocol

BMJ Open
2024-08 | Journal article
DOI: 10.1136/bmjopen-2023-083617
Contributors: Rita Simões; Sarah Gulliford; Beatrice Seddon; Hakim-Moulay Dehbi; Martin Robinson; Sharon Forsyth; Ana Hughes; Piers Gaunt; Thuy-Giang Nguyen; Stephanie Elston et al.
Source: check_circle
Crossref

Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literature

Radiotherapy and Oncology
2023-09 | Journal article
DOI: 10.1016/j.radonc.2023.109739
Part of ISSN: 0167-8140
Contributors: Rita Simões; Yolanda Augustin; Sarah Gulliford; Hakim-Moulay Dehbi; Peter Hoskin; Elizabeth Miles; Kevin Harrington; Aisha B. Miah
Source: Self-asserted source
Rita Simoes

OncoFlash – Research Updates in a Flash! (August 2023 Edition)

Clinical Oncology
2023-08 | Journal article
DOI: 10.1016/j.clon.2023.06.009
Part of ISSN: 0936-6555
Contributors: C. Crockett; R. Simões
Source: Self-asserted source
Rita Simoes

OncoFlash – Research Updates in a Flash! (June 2023 edition)

Clinical Oncology
2023-06 | Journal article
DOI: 10.1016/j.clon.2023.04.005
Part of ISSN: 0936-6555
Contributors: C. Crockett; R. Simões
Source: Self-asserted source
Rita Simoes

MO-0149 Development of novel outlining normal tissue structures for limb soft tissue sarcoma.

Radiotherapy and Oncology
2023-05 | Journal article
DOI: 10.1016/s0167-8140(23)08340-8
Part of ISSN: 0167-8140
Contributors: R. Simoes; P. Shah; Y. Augustin; S. Gulliford; P. Hoskin; E. Miles; K. Harrington; A. Miah
Source: Self-asserted source
Rita Simoes

MO-0390 Evaluating intra-breath-hold variation in IMAT breast boost patients delivered in DIBH

Radiotherapy and Oncology
2023-05 | Journal article
DOI: 10.1016/s0167-8140(23)08384-6
Part of ISSN: 0167-8140
Contributors: C. Maguire; S. Moinuddin; A. Webster; R. Simoes; S. Wickers
Source: Self-asserted source
Rita Simoes

MO-0947 Lessons learned from RT toxicity outcomes from UK VorteX and IMRiS trials for limb sarcoma

Radiotherapy and Oncology
2023-05 | Journal article
DOI: 10.1016/s0167-8140(23)08487-6
Part of ISSN: 0167-8140
Contributors: R. Simoes; H. Dehbi; S. Gulliford; B. Seddon; M. Robinson; P. Hoskin; S. Forsyth; L. White; P. Gaunt; A. Hughes et al.
Source: Self-asserted source
Rita Simoes

PO-2279 Preliminary analysis of subcutaneous tissue fibrosis and dose-volume relationships for limb sarcoma

Radiotherapy and Oncology
2023-05 | Journal article
DOI: 10.1016/s0167-8140(23)67194-4
Part of ISSN: 0167-8140
Contributors: R. Simoes; S. Gulliford; B. Seddon; M. Robinson; S. Forsyth; L. White; H. Dehbi; P. Gaunt; A. Hughes; E. Miles et al.
Source: Self-asserted source
Rita Simoes

PO-2292 The impact of a neuro-oncology RTT advanced practitioner in radiotherapy and proton beam therapy

Radiotherapy and Oncology
2023-05 | Journal article
DOI: 10.1016/s0167-8140(23)67207-x
Part of ISSN: 0167-8140
Contributors: K. Santhagunanathan; A. Webster; R. Simoes
Source: Self-asserted source
Rita Simoes

OncoFlash – Research Updates in a Flash! (April 2023)

Clinical Oncology
2023-04 | Journal article
DOI: 10.1016/j.clon.2023.02.016
Part of ISSN: 0936-6555
Contributors: R. Simões; K.T. Jayaprakash
Source: Self-asserted source
Rita Simoes

Preliminary fatigue patient-reported outcomes within the PredicT B

British Sarcoma Group meeting 2023
2023-03 | Conference poster
Contributors: Rita Simoes; Elizabeth Barquin; Steven Edmunds; Thuy-Giang Nguyen; Stephanie Elston; Shane Zaidi; Aisha Miah
Source: Self-asserted source
Rita Simoes

Preliminary fatigue patient-reported outcomes within the PredicT B study

British Sarcoma Group conference
2023-03-22 | Conference poster
Contributors: Rita Simoes
Source: Self-asserted source
Rita Simoes

OncoFlash – Research Updates in a Flash! (February 2023)

Clinical Oncology
2023-02 | Journal article
DOI: 10.1016/j.clon.2022.12.011
Part of ISSN: 0936-6555
Contributors: R. Simões; K.T. Jayaprakash
Source: Self-asserted source
Rita Simoes

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer

Clinical and Translational Radiation Oncology
2023-01 | Journal article
DOI: 10.1016/j.ctro.2022.11.010
Part of ISSN: 2405-6308
Contributors: David J. Thomson; Clare Cruickshank; Helen Baines; Russell Banner; Matthew Beasley; Guy Betts; Helen Bulbeck; Frances Charlwood; Judith Christian; Matthew Clarke et al.
Source: Self-asserted source
Rita Simoes

OncoFlash–Research Updates in a Flash! (December 2022)

Clinical Oncology
2022-12 | Journal article
DOI: 10.1016/j.clon.2022.10.013
Part of ISSN: 0936-6555
Contributors: R. Simões; K.T. Jayaprakash
Source: Self-asserted source
Rita Simoes

OncoFlash – Research Updates in a Flash! (October 2022)

Clinical Oncology
2022-10 | Journal article
DOI: 10.1016/j.clon.2022.09.001
Part of ISSN: 0936-6555
Contributors: R. Simões; K. Thippu Jayaprakash
Source: Self-asserted source
Rita Simoes

OncoFlash – Research Updates in a Flash! (August 2022)

Clinical Oncology
2022-08 | Journal article
DOI: 10.1016/j.clon.2022.06.009
Part of ISSN: 0936-6555
Contributors: R. Simões; K.T. Jayaprakash
Source: Self-asserted source
Rita Simoes

OncoFlash – Research Updates in a Flash! (June 2022)

Clinical Oncology
2022-06 | Journal article
DOI: 10.1016/j.clon.2022.04.010
Part of ISSN: 0936-6555
Contributors: R. Simões; K.T. Jayaprakash
Source: Self-asserted source
Rita Simoes

SP-0868 Moving countries: How does it work? RTT

Radiotherapy and Oncology
2022-05 | Journal article
DOI: 10.1016/s0167-8140(22)04056-7
Part of ISSN: 0167-8140
Contributors: R. Simoes
Source: Self-asserted source
Rita Simoes

Comparison of radiotherapy toxicity outcomes of patients with extremity soft tissue sarcoma treated within the VorteX and IMRiS clinical trials -

British Sarcoma Group conference
2022-03 | Conference paper
Contributors: Rita Simoes
Source: Self-asserted source
Rita Simoes

OC-0014:Results from CompARE phase III RCT: Dose Escalated Chemoradiation vs control in oropharyngeal cancer

ICHNO-ECHNO 2022
2022-03 | Conference abstract
Contributors: Rita Simoes
Source: Self-asserted source
Rita Simoes

OC-0035 Harms and Quality of Life Results of the Dose Escalated Chemoradiation Arm in CompARE phase III RCT

ICHNO-ECHNO 2022
2022-03 | Conference abstract
Contributors: Rita Simoes
Source: Self-asserted source
Rita Simoes

Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: a systematic review of the literature.

2022-03 | Conference poster
Contributors: Rita Simoes
Source: Self-asserted source
Rita Simoes

866P ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced (LA) squamous cell carcinoma of the head and neck (HNSCC)

Annals of Oncology
2021-09 | Journal article
DOI: 10.1016/j.annonc.2021.08.1276
Part of ISSN: 0923-7534
Contributors: M. Forster; R. Mendes; T. Guerrero Urbano; M. Evans; M. Lei; V. Spanswick; E. Miles; R. Simões; G. Wheeler; S. Forsyth et al.
Source: Self-asserted source
Rita Simoes

FP04.02 Feasibility of Radiotherapy Planning in the First 50 Patients Recruited to the ADSCaN Clinical Trial

Journal of Thoracic Oncology
2021-03 | Journal article
DOI: 10.1016/j.jtho.2021.01.089
Part of ISSN: 1556-0864
Contributors: R. Mir; C. Faivre-Finn; C. Lawless; E. Mccartney; C. Peedell; T. Pope; A. Shaw; R. Simoes; M. Hatton
Source: Self-asserted source
Rita Simoes

PO-1879: A novel and objective plan evaluation tool for dose escalation in NSCLC within the ADCSCaN trial

Radiotherapy and Oncology
2020-11 | Journal article
DOI: 10.1016/s0167-8140(21)01897-1
Part of ISSN: 0167-8140
Contributors: A.R. Lopes Simões; R. Mir; C. Lawless; A. Shaw; C. Peedell; T. Pope; J. Lester; D. Landau; C. Faivre-Finn; H. Matthew
Source: Self-asserted source
Rita Simoes

SP-0639: What is new in radiotherapy for soft tissue sarcoma?

Radiotherapy and Oncology
2020-11 | Journal article
DOI: 10.1016/s0167-8140(21)00661-7
Part of ISSN: 0167-8140
Contributors: A.R. Lopes Simões
Source: Self-asserted source
Rita Simoes

IMRiS phase II study of IMRT in limb sarcomas: Results of the pre-trial QA facility questionnaire and workshop

Radiography
2020-02 | Journal article | Author
DOI: 10.1016/j.radi.2019.08.006
Part of ISSN: 1078-8174
Contributors: Rita Simoes; E. Miles; H. Yang; F. Le Grange; R. Bhat; S. Forsyth; B. Seddon
Source: Self-asserted source
Rita Simoes
grade
Preferred source (of 2)‎

Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials

Clinical Oncology
2020-02 | Journal article
DOI: 10.1016/j.clon.2019.09.054
Part of ISSN: 0936-6555
Contributors: H. Yang; R. Mir; P. Díez; Y. Tsang; J. Conibear; R. Simões; S. Cox; A. Webster; Z. Nabi; D. Eaton et al.
Source: Self-asserted source
Rita Simoes

Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study

BMJ Open
2019-01 | Journal article
DOI: 10.1136/bmjopen-2017-019903
Part of ISSN: 2044-6055
Part of ISSN: 2044-6055
Contributors: Matthew Q F Hatton; Claire Anne Lawless; Corinne Faivre-Finn; David Landau; Jason F Lester; John Fenwick; Rita Simões; Elaine McCartney; Kathleen Anne Boyd; Tom Haswell et al.
Source: Self-asserted source
Rita Simoes

PO-1068: ADSCAN: Feasibility of implementing adequate technology for a ‘pick the winner’ trial in lung cancer

Radiotherapy and Oncology
2018-04 | Journal article
DOI: 10.1016/s0167-8140(18)31378-1
Part of ISSN: 0167-8140
Contributors: R. Simões; E. Patel; N. Groom; C. Lawless; A. Shaw; J. Paul; D. Eaton; J. Lester; D. Landau; C. Faivre-Finn et al.
Source: Self-asserted source
Rita Simoes

OC-0449: A novel and objective plan evaluation for limb sarcomas IMRT in the IMRiS phase II trial

Radiotherapy and Oncology
2017-05 | Journal article
DOI: 10.1016/s0167-8140(17)30891-5
Part of ISSN: 0167-8140
Contributors: R. Simões; H. Yang; R. Patel; F. Le Grange; S. Beare; E. Miles; B. Seddon
Source: Self-asserted source
Rita Simoes

PO-0742: Target delineation conformity in extremity STS within the UK phase II multi-centre IMRiS trial

Radiotherapy and Oncology
2017-05 | Journal article
DOI: 10.1016/s0167-8140(17)31179-9
Part of ISSN: 0167-8140
Contributors: H. Yang; R. Simões; F. Le Grange; S. Forsyth; D. Eaton; B. Seddon
Source: Self-asserted source
Rita Simoes

PO-1023: Quality assurance for IMRiS phase II study of IMRT in sarcomas: a survey of limb immobilisation

Radiotherapy and Oncology
2016-04 | Journal article
DOI: 10.1016/s0167-8140(16)32273-3
Part of ISSN: 0167-8140
Contributors: R. Simões; E. Miles; F. Le Grange; R. Bhat; B. Seddon
Source: Self-asserted source
Rita Simoes

Peer review (10 reviews for 3 publications/grants)

Review activity for BMJ open. (3)
Review activity for Clinical oncology. (5)
Review activity for Technical innovations & patient support in radiation oncology. (2)
How many people are using ORCID?